Provention bio to present at the jefferies global healthcare conference

Red bank, n.j. , june 3, 2022 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in a corporate presentation at the jefferies global healthcare conference on wednesday, june 8 th 2022 at 9:00 am est in new york city.
PRVB Ratings Summary
PRVB Quant Ranking